Skip to main content
Premium Trial:

Request an Annual Quote

What, No Big Names Could Make It?

Bill Gates, Eric Lander, Maynard Olson, Leena Peltonen, and George Church led a panel discussion on personal genomics at the University of Washington on Wednesday night, covering the state of genomics and the effect of studies linking genetic variation to disease. Deepak at bbgm writes, "Perhaps one of the things that jumped out at me was the general popular belief (which is hardly surprising) that it is a gene or a few genes that can be altered or fixed to address a 'problem'. We're just beginning to grasp the relevance of pathways, of epigenetics, etc, so the long term implications of what we know (and don't) are still a little fuzzy."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.